The disruption of these processes can be observed by measuring specific T2DM risk factors, such as mass index (BMI), lipid profile, body fat index (BFI), glucose tolerance and insulin sensitivity tests, and plasma inflammatory markers [5–8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.